ReNerve Limited
Research ReNerve Limited (RNV.AX) on Bullrun: market cap AUD 13.36M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRNV.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 13.36M
- Financial periodFY2026
- RevenueAUD 510.36K
- Revenue growth87.8%
- Net income-AUD 5.57M
- Free cash flow-AUD 5.95M
- Gross margin53.2%
Valuation Snapshot
latest market cap is AUD 13.36M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 510.36K | -AUD 5.57M | -AUD 5.95M | 53.2% | n/a | AUD 1.49M | AUD 201.55K | AUD 3.18M |
| FY2025 | AUD 271.71K | -AUD 3.73M | -AUD 3.05M | 90.0% | -0.03 | AUD 4.75M | n/a | AUD 5.20M |
| FY2024 | AUD 177.37K | -AUD 2.98M | -AUD 2.30M | 99.6% | -0.02 | AUD 7.49M | AUD 21.84K | AUD 7.42M |
| FY2023 | AUD 128.49K | -AUD 1.80M | -AUD 1.52M | 100.0% | -0.01 | n/a | n/a | AUD 0 |
| FY2022 | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 13.36M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About ReNerve Limited
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ReNerve Limited's market cap?
ReNerve Limited's market capitalization is AUD 13.36M.
What does ReNerve Limited do?
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand.